Forex News

U.S. Dollar Showing Modest Move Back To The Upside

After trending lower over the past few days, the value of the U.S. dollar has moved modestly higher over the course of trading on Wednesday.

RTTNews | 560 days ago

Euro Weakens As German Inflation Eases More Than Expected

The euro fell against its major counterparts in the New York session on Wednesday, as German inflation eased in November to the lowest level in nearly two-and-a-half years.

RTTNews | 560 days ago

Canadian Market Modestly Higher At Noon

The Canadian market is turning in a mixed performance on Wednesday. While optimism about the outlook for interest rates contribute a bit to market's rise, growth worries and caution ahead of some crucial U.S. and Canadian economic data appear to be limiting the upside.

RTTNews | 560 days ago

U.S. Dollar Erases Losses Against Majors

The U.S. dollar rose against its most major counterparts in the European session on Wednesday, after falling in the previous session on the back of dovish remarks from Fed Governor Christopher Waller.

RTTNews | 560 days ago

AbbVie Announces Topline Results From Phase 2 LUMINOSITY Trial Of Telisotuzumab-Vedotin

Biopharmaceutical company AbbVie, Inc. (ABBV) announced Wednesday topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC). The trial demonstrated compelling clinical benefits across key endpoints.

RTTNews | 560 days ago

Philips' Stock Hit By FDA Warning Against DreamStation 2 CPAP Machines

Shares of Philips Electronics NV were losing around 5 percent in Amsterdam trading as well as in the pre-market activity on the NYSE after the U.S. regulator warned against the safety of Dutch consumer electronics giant's DreamStation 2 Continuous Positive Airway Pressure or CPAP Machines. The Food and Drug Administration or FDA said it is alerting patients and healthcare providers of an emerging

RTTNews | 560 days ago

Pasithea Announces Receipt Of FDA Response Of Pre-IND Meeting For PAS-004 Clinical Development

Biotechnology company Pasithea Therapeutics Corp. (KTTA) announced Wednesday receipt of written responses to questions submitted for a Type 2 pre-Investigational New Drug Application (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding clinical development plan for PAS-004.

RTTNews | 560 days ago

more news

UniQure Says FDA Clears IND Application For AMT-191 Gene Therapy For Fabry Disease

Gene therapy company uniQure N.V. (QURE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AMT-191, the Company's gene therapy candidate for Fabry disease.

RTTNews | 560 days ago

U.S. GDP Jumps More Than Previously Estimated In Q3

Revised data released by the Commerce Department on Wednesday showed the U.S. economy grew faster than previously estimated in the third quarter of 2023. The Commerce Department said the jump by real gross domestic product in the third quarter was upwardly revised to 5.2 percent from the previously reported 4.9 percent.

RTTNews | 560 days ago

UK Mortgage Approvals Hit 3-Month High

UK mortgage approvals increased more than expected to a three-month high in October signaling a slowdown in the housing market downturn after the central bank kept interest rates unchanged in September and November. Net mortgage approvals for house purchases rose to a three-month high of 47,400 in October from 43,700 in September, the Bank of England reported Wednesday.

RTTNews | 560 days ago